For the first time a logical connexion between the thymus and muscle has been established. It has been known for nearly sixty years that the thymus is usually abnormal in myasthenia gravis and that 10-15 % of cases have a thymic tumour, the latter cases being clinically more severe. Now it has been shown that the titre of antimuscle antibody is greatest in the presence of a thymoma but that it need not necessarily be associated with clinical or latent myasthenia .
Thus the present position is that there is no doubt that disordered immunological tolerance is common in myasthenia gravis but no evidence as to whether it is primary or secondary. When in 1960 I proposed this hypothesis Miller had not yet published his work establishing the immunological role of the thymus so it was necessary to suggest a possible mechanism for the neuromuscular disorder. At that time I favoured the idea that antibody against the receptor substance of the muscle endplate acted as a curare-like competitive blocking substance. At present there is no evidence to support this, and the nature of the defect remains obscure.
Neuromuscular Transmission I cannot review here the mass of information on the functional disorder of neuromuscular transmission and abnormal responses to drugs acting at the endplate of muscle. I have recently analysed the data (Simpson 1968 ) and concluded that all can be accounted for by the structural changes demonstrated by Coers & Woolf (1959) . These are presumably the result of a substance elaborated by the thymus and capable of passing the placental barrier. In my opinion it is a globulin of the antibody type.
Thymectomy
The first thymectomy for myasthenia gravis was performed by Sauerbruck in 1912 but there was little interest in the operation until Blalock et al. (1941) reported a series. Later American reports were discouraging although Keynes (1946 Keynes ( , 1955 found it a valuable procedure. An independent study by Simpson (1958) confirmed the claims of Keynes that the operation was valuable if no thymoma was present, and review of the various American statistics showed that they were consistent with this. The operation was most effective if performed during the 'active' stage of disease and women gained most benefit. Other methods of destroying the thymus (radiotherapy, steroids, carotid sinus denervation) are less direct and hence inferior since the operation is so safe in skilled hands. Working closely with Mr Andrew Logan in Edinburgh and Mr Kenneth Fraser in Glasgow during the last twelve years there have been no post-operative deaths in patients under my care. For this reason I continue to rely on thymectomy, but it must be observed that in the last ten years there have been great improvements in medical management, notably in the wider use of pyridostigmine, better recognition of the difference between myasthenic and cholinergic crisis, greater familiarity with the use of edrophonium to evaluate the cause of weakness, and tremendous advance in the management of ventilatory failure. It might well be that these advances have restored the balance in favour of drug therapy. In the myasthenic the thymus is often abnormal histologically. It may contain many more germinal centres than are seen in health. The similarity of the histological picture to that of the thyroid in Hashimoto's disease led to suggest that myasthenia gravis was an autoimmune disease, and Professor Simpson (1960) has taken a similar view. Even in the 10-20% of cases in which a thymoma is present there are usually many germinal centres in the 'normal' thymic tissue which is adjacent to the tumour (Bernatz et al. 1961) . Histologically the other features of this disease are in the muscles, where changes in the endplates occur and there is muscle fibre necrosis and the accumulation of lymphocytes in lymphorrhagic areas.
As in many immunological or autoallergic disorders, it is the change at tissue level which is important but the associated release of autoantibodies is easier to study. These autoantibodies may in this case include antinuclear factor and thyroid antibodies (Wright & Kerr 1967) , and the association of myasthenia gravis with evidence of a more widespread immune disorder is not uncommon.
Autoantibody which reacts with peripheral muscle is detectable by fluorescent tests in the blood of over a third of patients with myasthenia gravis and in almost every case in which a tumour is present. The muscle-reacting antibody also reacts with thymic epithelial or 'myoid' cells, and absorption with thymus abolishes its muscle reactivity (van der Geld & Strauss 1966). The cross-reaction with muscle may therefore be a side-effect of an antibody response to disease or destruction of the thymus. This view is supported by the histology of the thymoma, which in these cases is always of the epithelial cell variety, arising in a type of cell which, in its early development, often resembles striated muscle. The cross-striated appearance of the similar myoid cells in the thymus of the turtle has been beautifully demonstrated by . If myasthenia gravis is an autoallergic disorder it should be possible to provoke a similar reaction in animals and this has now been achieved by Goldstein & Whittingham (1966) . Guinea-pigs which were immunized, either with thymus or with skeletal muscle, developed many of the features of myasthenia gravis, with a demonstrable neuromuscular block, lymphocytic collections round Hassall's corpuscles, and a circulating antibody to thymic epithelial cells which crossreacted with skeletal muscle.
The circulating antibody in myasthenia gravis does not, however, attach to the motor endplate itself and is not a constant feature of the human disease. This suggests that more than one factor must be concerned or else that the antibody released into the circulation is unimportant. Not infrequently, the infant born of a myasthenic mother may have transient neonatal myasthenia, and it has often been argued that this must be due to a circulating factor. Yet there are cases in which neither the mother nor the infant has detectable autoantibodies in the blood (Oosterhuis et al. 1966 ). If there is a humoral factor which crosses the placenta it does not appear to be muscle-binding antibody of the commonly accepted type.
In opposition to the view that myasthenia gravis is an autoallergic disease it has been argued that symptoms should be more consistently reversible by thymectomy, especially in those cases with circulating antibodies. This ignores the effects of established muscle atrophy and endplate disease, which may not always be reversible even if they are successfully arrested. Quite apart from this the response to treatment may differ when certain distinctive clinical or laboratory features are present, as in those male patients whose symptoms are limited to the extraocular muscles (Parkes & McKinna 1966) . Perhaps these patients represent a separate disease entity.
A great deal about myasthenia gravis remains to be explained. From the practical standpoint, the circulating antibody provides a useful marker of the disease, especially in those cases which are due to tumour. When it is present, an immune disorder of the thymus may be presumed even if, radiologically, this organ is normal in size. When it is absent, myasthenia gravis may still be severe but it is very unlikely to be associated with a thymoma.
